PharmiWeb1h
BioNxt Accelerates R&D with Move to Gen-Plus Laboratory in Munich, Germany, Expanding Drug Delivery Research Capabilities
VANCOUVER, BC / ACCESS Newswire / January 21, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC PINK:BNXTF)(FSE:BXT), a bioscience company specializing in advanced drug delivery ...
PharmiWeb23h
Oral Irrigator Market Size, Share to Grow by USD 1,870.4 Million by 2032, with a CAGR of 6.6%
The Oral Irrigator Market, valued at USD 1,065.2 million in 2023, is poised for significant expansion, projected to reach USD ...
PharmiWeb23h
Leaps by Bayer Announces One of the Largest Global Surveys of Society’s Attitudes Toward Breakthrough Technologies
The data uncover broad optimism as well as stark regional disparities and cultural obstacles in the West that must be ...
PharmiWeb3h
DocMorris grows 6.7 per cent in 2024 and accelerates Rx growth in the fourth quarter
Development of SalesDocMorris grows 6.7 per cent in 2024 and accelerates Rx growth in the fourth quarter 21.01.2025 / 06:58 CET/CESTPress releaseDocMorris grows 6.7 per cent in 2024 and accelerates Rx ...
PharmiWeb23h
Insights from Life Science Research Drive Medical Device Innovation
The medical device industry is at the forefront of innovation, transforming healthcare delivery through groundbreaking technologies. At the center of this progress are life science innovations, which ...
PharmiWeb9h
My Nursing Laboratory Introduces Essential Self-Care Tools for Healthcare Professionals
Supporting Nurses and Essential Workers with Thoughtfully Designed Products That Promote Mental Wellness, Confidence, and Community Connection GREENWICH, CT / ACCESS Newswire / January 20, 2025 / ...
PharmiWeb18h
Biodefense Market Size, Trends, Growth Forecast, and Insights (2023-2032): Emerging Opportunities in Protecting Against Biological Threats
What is Biodefense?Biodefense Market refers to strategies and technologies designed to protect populations from biological threats, including bioterrorism and accidental biological exposures. The use ...
PharmiWeb23h
European Commission expands Jemperli (dostarlimab)…
GSK plc (LSE/NYSE: GSK) today announced the European Commission has approved Jemperli (dostarlimab) in combination with chemotherapy (carboplatin and paclitaxel) for first-line treatment of adult ...
PharmiWeb19h
Innovative Trials appoints first Non-Executive Chair as it targets significant business growth
Innovative Trials, a specialist clinical trial patient engagement, recruitment, and retention company, has today, Monday 20 January 2025, announced John Watkinson MBE as its first-ever Non-Executive ...
PharmiWeb18h
Ethema to Present at Microcap Conference in Atlantic City on January 28-30, 2025
WEST PALM BEACH, FL / ACCESS Newswire / January 20, 2025 / Ethema Health Corporation (OTCPINK:GRST) ("Ethema" "GRST" or the "Company"), is pleased to announce its participation in The Microcap ...
PharmiWeb17h
New Open-Source GMP Platform Now Available to Pharma Manufacturers
Scalable, User-Friendly Data Management Solution Offers Innovation, Integration, and Transparency for Pharma Operations. SOFIA, BG / ACCESS Newswire / January 20, 2025 / A leading global ...
PharmiWeb23h
Cutting-Edge Technologies and Animal Models Advancing Life Science Research on Shigella Infection Mechanisms in Humans
Shigella infection can cause severe discomfort in humans, emphasizing the need for mechanisms to understand it. With new technologies and animal models, you can see how far life science researchers ...